Novartis opens new manufacturing facility in California
The opening of the Carlsbad manufacturing facility allows Novartis to seamlessly meet future demand for radioligand therapy, adding additional capacity and augmenting the company’s world-class supply chain capabilities.
Discover our medicines
See how our innovative medicines are addressing society's greatest health challenges.
Commitment to patients
From research and development to expanding access, uncover our commitment to improving people's lives.
Inspired by purpose
Learn about our people and culture, and how we're driven by our mission to reimagine medicine.
Latest News
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
